301 related articles for article (PubMed ID: 36084708)
1. Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases.
Ma C; Han L; Zhu Z; Heng Pang C; Pan G
Biochem Pharmacol; 2022 Nov; 205():115242. PubMed ID: 36084708
[TBL] [Abstract][Full Text] [Related]
2. An overview of ferroptosis in non-alcoholic fatty liver disease.
Wang S; Liu Z; Geng J; Li L; Feng X
Biomed Pharmacother; 2022 Sep; 153():113374. PubMed ID: 35834990
[TBL] [Abstract][Full Text] [Related]
3. Iron metabolism and ferroptosis in nonalcoholic fatty liver disease: what is our next step?
Shen X; Yu Z; Wei C; Hu C; Chen J
Am J Physiol Endocrinol Metab; 2024 Jun; 326(6):E767-E775. PubMed ID: 38506752
[TBL] [Abstract][Full Text] [Related]
4. Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies.
Zhang H; Zhang E; Hu H
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829889
[TBL] [Abstract][Full Text] [Related]
5. Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease.
Guo CH; Chen PC; Ko WS
Int J Med Sci; 2013; 10(6):730-7. PubMed ID: 23630437
[TBL] [Abstract][Full Text] [Related]
6. The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease.
Feldman A; Aigner E; Weghuber D; Paulmichl K
Biomed Res Int; 2015; 2015():287401. PubMed ID: 26273604
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Vetuschi A; Cappariello A; Onori P; Gaudio E; Latella G; Pompili S; Sferra R
Eur J Histochem; 2022 Jun; 66(3):. PubMed ID: 35726536
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications.
Cheng Z; Chu H; Zhu Q; Yang L
Front Nutr; 2023; 10():1090338. PubMed ID: 36992907
[TBL] [Abstract][Full Text] [Related]
9. Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease.
Sui Y; Geng X; Wang Z; Zhang J; Yang Y; Meng Z
Metabolism; 2024 Jun; 157():155953. PubMed ID: 38885833
[TBL] [Abstract][Full Text] [Related]
10. Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells.
Liu H; Yan J; Guan F; Jin Z; Xie J; Wang C; Liu M; Liu J
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Apr; 1868(4):159287. PubMed ID: 36690321
[TBL] [Abstract][Full Text] [Related]
11. Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease.
Zhao S; Guo Y; Yin X
Front Biosci (Landmark Ed); 2023 Dec; 28(12):332. PubMed ID: 38179745
[TBL] [Abstract][Full Text] [Related]
12. [Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease].
Yuan XW; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):262-267. PubMed ID: 38584112
[TBL] [Abstract][Full Text] [Related]
13. Stable isotope-based flux studies in nonalcoholic fatty liver disease.
McCullough A; Previs S; Kasumov T
Pharmacol Ther; 2018 Jan; 181():22-33. PubMed ID: 28720429
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?
Feng G; Byrne CD; Targher G; Wang F; Zheng MH
Liver Int; 2022 Jul; 42(7):1496-1502. PubMed ID: 35007392
[TBL] [Abstract][Full Text] [Related]
15. The multifaceted role of ferroptosis in liver disease.
Chen J; Li X; Ge C; Min J; Wang F
Cell Death Differ; 2022 Mar; 29(3):467-480. PubMed ID: 35075250
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis as a new therapeutic opportunity for nonviral liver disease.
Jia M; Zhang H; Qin Q; Hou Y; Zhang X; Chen D; Zhang H; Chen Y
Eur J Pharmacol; 2021 Oct; 908():174319. PubMed ID: 34252441
[TBL] [Abstract][Full Text] [Related]
17. Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis.
Liu B; Yi W; Mao X; Yang L; Rao C
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E925-E937. PubMed ID: 33813878
[TBL] [Abstract][Full Text] [Related]
18. Iron and non-alcoholic fatty liver disease.
Britton LJ; Subramaniam VN; Crawford DH
World J Gastroenterol; 2016 Sep; 22(36):8112-22. PubMed ID: 27688653
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
[TBL] [Abstract][Full Text] [Related]
20. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
